Coe Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $807K | Buy |
2,587
+23
| +0.9% | +$7.18K | 0.76% | 38 |
|
|
2021
Q1 | $817K | Sell |
2,564
-68
| -3% | -$21.7K | 0.82% | 36 |
|
|
2020
Q4 | $853K | Sell |
2,632
-11
| -0.4% | -$3.57K | 0.93% | 34 |
|
|
2020
Q3 | $732K | Sell |
2,643
-136
| -5% | -$37.7K | 0.98% | 32 |
|
|
2020
Q2 | $671K | Sell |
2,779
-60
| -2% | -$14.5K | 1% | 35 |
|
|
2020
Q1 | $412K | Buy |
2,839
+209
| +8% | +$30.3K | 0.69% | 45 |
|
|
2019
Q4 | $449K | Sell |
2,630
-682
| -21% | -$116K | 0.57% | 58 |
|
|
2019
Q3 | $589K | Buy |
3,312
+105
| +3% | +$18.7K | 0.65% | 58 |
|
|
2019
Q2 | $835K | Buy |
3,207
+290
| +10% | +$75.5K | 0.92% | 39 |
|
|
2019
Q1 | $833K | Sell |
2,917
-34
| -1% | -$9.71K | 0.97% | 37 |
|
|
2018
Q4 | $959K | Sell |
2,951
-588
| -17% | -$191K | 1.18% | 27 |
|
|
2018
Q3 | $1.59M | Buy |
3,539
+95
| +3% | +$42.7K | 1.57% | 26 |
|
|
2018
Q2 | $1.41M | Sell |
3,444
-1,101
| -24% | -$450K | 1.57% | 28 |
|
|
2018
Q1 | $1.32M | Sell |
4,545
-1,405
| -24% | -$409K | 1.43% | 29 |
|
|
2017
Q4 | $1.12M | Sell |
5,950
-160
| -3% | -$30K | 1.18% | 34 |
|
|
2017
Q3 | $1.03M | Sell |
6,110
-480
| -7% | -$80.9K | 1.07% | 37 |
|
|
2017
Q2 | $944K | Buy |
6,590
+800
| +14% | +$115K | 1.07% | 36 |
|
|
2017
Q1 | $725K | Buy |
5,790
+275
| +5% | +$34.4K | 0.87% | 45 |
|
|
2016
Q4 | $621K | Sell |
5,515
-19,953
| -78% | -$2.25M | 0.8% | 47 |
|
|
2016
Q3 | $2.82M | Sell |
25,468
-2,960
| -10% | -$328K | 0.91% | 22 |
|
|
2016
Q2 | $3.11M | Buy |
28,428
+9,407
| +49% | +$1.03M | 1.07% | 22 |
|
|
2016
Q1 | $1.8M | Sell |
19,021
-66,272
| -78% | -$6.28M | 0.58% | 59 |
|
|
2015
Q4 | $7.7M | Buy |
85,293
+78,139
| +1,092% | +$7.05M | 3.06% | 1 |
|
|
2015
Q3 | $664K | Sell |
7,154
-35,614
| -83% | -$3.3M | 0.25% | 116 |
|
|
2015
Q2 | $2.81M | Buy |
+42,768
| New | +$2.81M | 1.02% | 20 |
|